Literature DB >> 32575833

Independent Predictive Ability of Procalcitonin of Acute Kidney Injury among Critically Ill Patients.

Ya-Ting Huang1, Min-Yu Lai1, Wei-Chih Kan2,3, Chih-Chung Shiao4,5.   

Abstract

It is unclear whether serum procalcitonin (PCT) levels rise in patients with acute kidney injury (AKI), and it is also unclear whether the elevation of PCT levels in this setting is independent of the existence of infection and impaired renal clearance. We conducted a retrospective study in a regional teaching hospital in Taiwan to evaluate the AKI-predictive ability of serum PCT among critically ill patients. We enrolled 330 patients (mean age, 70.5 ± 16.4 years; 57.0% men) who were admitted to the intensive care unit (ICU) from 1 July 2016, to 31 December 2016, and who had serum PCT measurement performed within 24 h after ICU admission. We used the generalized additive model and generalized linear model to evaluate the association of serum PCT levels and renal function variables. In addition, we used the multivariate logistic regression method to demonstrate serum PCT level as an independent predictor of AKI in both the non-infected patients (odds ratio (OR) = 1.38, 95% confidence interval (CI) = 1.12-1.71, p = 0.003) and the infected patients (OR = 1.23, 95% CI = 1.03-1.46, p = 0.020). In conclusion, serum PCT level at ICU admission is an independent predictor of developing AKI irrespective of infection among critically ill patients.

Entities:  

Keywords:  acute kidney injury; infection; predictor; procalcitonin

Year:  2020        PMID: 32575833     DOI: 10.3390/jcm9061939

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  6 in total

1.  Clinical Features and Outcomes of COVID-19 Patients with Acute Kidney Injury and Acute Kidney Injury on Chronic Kidney Disease.

Authors:  Zhifeng Xu; Yuanyuan Zhang; Chun Zhang; Fei Xiong; Jianduan Zhang; Jing Xiong
Journal:  Aging Dis       Date:  2022-06-01       Impact factor: 9.968

Review 2.  Sepsis and Acute Kidney Injury: A Review Focusing on the Bidirectional Interplay.

Authors:  Yu-Ming Chang; Yu-Ting Chou; Wei-Chih Kan; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2022-08-15       Impact factor: 6.208

3.  A risk score based on procalcitonin for predicting acute kidney injury in COVID-19 patients.

Authors:  Ruo Ran Wang; Min He; Yan Kang
Journal:  J Clin Lab Anal       Date:  2021-05-25       Impact factor: 2.352

Review 4.  Predictive Ability of Procalcitonin for Acute Kidney Injury: A Narrative Review Focusing on the Interference of Infection.

Authors:  Wei-Chih Kan; Ya-Ting Huang; Vin-Cent Wu; Chih-Chung Shiao
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

5.  PD-1 and PD-L1 Expression on Circulating Lymphocytes as a Marker of Epstein-Barr Virus Reactivation-Associated Proliferative Glomerulonephritis.

Authors:  Ewelina Grywalska; Iwona Smarz-Widelska; Izabela Korona-Głowniak; Sebastian Mertowski; Krzysztof Gosik; Anna Hymos; Jarosław Ludian; Paulina Niedźwiedzka-Rystwej; Jacek Roliński; Wojciech Załuska
Journal:  Int J Mol Sci       Date:  2020-10-27       Impact factor: 5.923

6.  Analysis of the diagnostic capabilities of urinary neutrophil gelatinase-associated lipocalin and serum procalcitonin for acute kidney injury at the early stage of critical care intensive care unit admission.

Authors:  Yuji Imoto; Ayano Wakasaki; Kumiko Izumida; Hiroshi Shimada; Kumiko Ohkubo; Yasumasa Kawano; Hiroyasu Ishikura; Akira Matsunaga
Journal:  J Clin Lab Anal       Date:  2021-06-08       Impact factor: 2.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.